胸腺肽联合抗生素对老年慢阻肺急性加重期的治疗效果

Thymosin Antibiotics for Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Elderly Period

目的探讨胸腺肽联合抗生素对老年慢阻肺急性加重期的治疗效果。方法选取我院2013年5月~2014年5月间收治的老年慢阻肺急性加重期患者100例,随机分为对照组和治疗组各50例,对照组采用抗生素的一般治疗,而治疗组采用胸腺肽联合抗生素治疗,比较两组临床疗效。结果对照组总有效率72.5%,治疗组总有效率94.8%,治疗组疗效明显优于对照组P〈0.05,具有统计学意义。两组患者临床症状和生活质量评分具有统计学意义。在治疗组在治疗过程中未发现不良反应产生,如过敏、肝功能损害等。结论胸腺肽联合抗生素对老年慢阻肺急性加重期的治疗效果显著,安全可靠,值得临床进一步推广应用。

Objective To investigate the Thymosin antibiotics in elderly acute exacerbation of COPD treatment. Methods 100 patients were randomly divided into the general treatment of the control group and treatment group from May 2013 to May 2014 in our hospital, 50 patients in the control group received antibiotics, but treatment thymosin antibiotic treatment group were compared clinical efficacy. Results The total efficiency of the control group was 72.5%, the total efficiency of the treatment group 94.8%, the treatment group than the control group, P〈0.05, statistically significant. Clinical symptoms and quality of life scores two groups was statistically significant. In the treatment group during treatment found no adverse reactions, such as allergies, liver dysfunction. Conclusion Thymosin antibiotics in elderly acute exacerbation of COPD treatment effect are remarkable, safe, and reliable, worthy of further clinical application.